NADPH‐diaphorase: A selective histochemical marker for striatal neurons containing both somatostatin‐ and avian pancreatic polypeptide (APP)‐like immunoreactivities
Abstract:Certain neurons in the brain are specifically and intensely stained by a histochemical method which demonstrates nicotinamide adenine dinucleotide phosphate NADPH-diaphorase activity. The cell types containing this enzyme in certain areas of the rat forebrain were examined by combining NADPH-diaphorase histochemistry with the indirect immunofluorescence technique. Neurons containing somatostatin- or avian pancreatic polypeptide (APP)-like immunoreactivities were found throughout the forebrain including the str… Show more
“…Brain blocks containing the forebrain were postfixed overnight, treated with 30% sucrose till they sunk and sectioned coronally (40 μm) on a freezing microtome. Sections were stained in series for: cresyl violet; NADPH diaphorase histochemistry using the method of Vincent with minor modifications (Vincent et al, 1983); neuronal nitric oxide synthase (nNOS) ICC; and active caspase-3 ICC. All ICC reactions were based on the avidin-biotin-peroxidase (ABC) labeling protocol using commercially available kits (Vector Labs, Burlingame, CA) and goat anti-rabbit IgG as a linker (Vector Labs).…”
Section: Histology Histochemistry and Immunocytochemistry (Icc)mentioning
Pyramidal relay neurons in limbic cortex are vulnerable to denervation lesions, i.e. pyramidal neurons in layer IIα of piriform cortex undergo transsynaptic apoptosis after lesions that interrupt their inputs from the olfactory bulb. We have previously established the role of inhibitory interneurons in elaborating signals that lead to the apoptosis of projection neurons in these lesion models, i.e. the upregulation of neuronal NOS and release of nitric oxide. Thus, we have proposed that cortical interneurons play an essential role in transducing injury to degenerative effects for nearby pyramidal neurons. In the present study, we extend the previous findings to a toxic model of degeneration of pyramidal neurons in the adult paralimbic cortex, i.e. after exposure to the NMDA channel blocker MK801. Our findings indicate that treatment of adult rats with MK801 in doses previously found to cause alterations in pyramidal neurons of the retrosplenial cortex (5 mg/kg) results in an active caspase 3 (+), ultrastructurally apoptotic type of cell death involving the same projection neurons of layer IIα that are also vulnerable to bulbotomy lesions. Interneurons of layer I are induced by MK801 treatment to higher levels of nNOS expression and the selective nNOS inhibitor BRNI ameliorates pyramidal cell apoptosis caused by MK801. Our results indicate that certain pyramidal neurons in piriform cortex are very sensitive to NMDA blockade as they are to disconnection from modalityspecific afferents and that inhibitory interneurons play significant roles in mediating various types of pro-apoptotic insults to cortical projection neurons via nNOS/NO signaling.
“…Brain blocks containing the forebrain were postfixed overnight, treated with 30% sucrose till they sunk and sectioned coronally (40 μm) on a freezing microtome. Sections were stained in series for: cresyl violet; NADPH diaphorase histochemistry using the method of Vincent with minor modifications (Vincent et al, 1983); neuronal nitric oxide synthase (nNOS) ICC; and active caspase-3 ICC. All ICC reactions were based on the avidin-biotin-peroxidase (ABC) labeling protocol using commercially available kits (Vector Labs, Burlingame, CA) and goat anti-rabbit IgG as a linker (Vector Labs).…”
Section: Histology Histochemistry and Immunocytochemistry (Icc)mentioning
Pyramidal relay neurons in limbic cortex are vulnerable to denervation lesions, i.e. pyramidal neurons in layer IIα of piriform cortex undergo transsynaptic apoptosis after lesions that interrupt their inputs from the olfactory bulb. We have previously established the role of inhibitory interneurons in elaborating signals that lead to the apoptosis of projection neurons in these lesion models, i.e. the upregulation of neuronal NOS and release of nitric oxide. Thus, we have proposed that cortical interneurons play an essential role in transducing injury to degenerative effects for nearby pyramidal neurons. In the present study, we extend the previous findings to a toxic model of degeneration of pyramidal neurons in the adult paralimbic cortex, i.e. after exposure to the NMDA channel blocker MK801. Our findings indicate that treatment of adult rats with MK801 in doses previously found to cause alterations in pyramidal neurons of the retrosplenial cortex (5 mg/kg) results in an active caspase 3 (+), ultrastructurally apoptotic type of cell death involving the same projection neurons of layer IIα that are also vulnerable to bulbotomy lesions. Interneurons of layer I are induced by MK801 treatment to higher levels of nNOS expression and the selective nNOS inhibitor BRNI ameliorates pyramidal cell apoptosis caused by MK801. Our results indicate that certain pyramidal neurons in piriform cortex are very sensitive to NMDA blockade as they are to disconnection from modalityspecific afferents and that inhibitory interneurons play significant roles in mediating various types of pro-apoptotic insults to cortical projection neurons via nNOS/NO signaling.
“…Whatever the precise cellular mechanisms, this observation serves an interesting coincidence with pathological characteristics of brains of patients with neurodegenerative disorders such as HD (25,26). The specific aspiny neuronal subpopulation containing NADPH diaphorase, which is colocalized with somatostatin and neuropeptide Y (33), is selectively spared in the degenerated striatum of HD patients (25,26).…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.